
4.86% volatility in Ocular Therapeutix Inc (OCUL) last month: This is a red flag warning
On Tuesday, Ocular Therapeutix Inc (NASDAQ: OCUL) was -0.68% drop from the session before settling in for the closing price of $12.56. A 52-week range
On Tuesday, Ocular Therapeutix Inc (NASDAQ: OCUL) was -0.68% drop from the session before settling in for the closing price of $12.56. A 52-week range
Ocular Therapeutix Inc (NASDAQ: OCUL) started the day on Thursday, with a price decrease of -1.60% at $12.3, before settling in for the price of
A new trading day began on Monday, with Ocular Therapeutix Inc (NASDAQ: OCUL) stock price up 3.61% from the previous day of trading, before settling
Ocular Therapeutix Inc (NASDAQ: OCUL) started the day on Wednesday, with a price increase of 3.55% at $11.96, before settling in for the price of
Ocular Therapeutix Inc (NASDAQ: OCUL) kicked off on Friday, down -0.44% from the previous trading day, before settling in for the closing price of $11.38.
A new trading day began on Tuesday, with Ocular Therapeutix Inc (NASDAQ: OCUL) stock price down -1.60% from the previous day of trading, before settling
Ocular Therapeutix Inc (NASDAQ: OCUL) on Tuesday, soared 3.23% from the previous trading day, before settling in for the closing price of $9.61. Within the
Ocular Therapeutix Inc (NASDAQ: OCUL) on Thursday, soared 1.69% from the previous trading day, before settling in for the closing price of $9.46. Within the
A new trading day began on Tuesday, with Ocular Therapeutix Inc (NASDAQ: OCUL) stock price down -1.94% from the previous day of trading, before settling
Ocular Therapeutix Inc (NASDAQ: OCUL) on Tuesday, soared 8.60% from the previous trading day, before settling in for the closing price of $8.37. Within the
Newsdaemon.com is a Business and Stock news website that covers extensive information on Stock markets and Equities. One of the key emphases of this portal is to widen readers’ knowledge of public and private capital sharing, both in updates and broad analysis.
Copyright © 2024 News Daemon, All rights reserved.